US 6482417
Stable pharmaceutical formulation comprising torsemide modification II
expired A61KA61K31/44A61K9/20
Quick answer
US patent 6482417 (Stable pharmaceutical formulation comprising torsemide modification II) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/44, A61K9/20, A61P, A61P7/10